Atlas Trials

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Clinical trial NCT02948569 · COMPLETED

Trial details

NCT number
NCT02948569
Sponsor
University of Missouri-Columbia
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2017-02-01
Primary completion
2017-12-18
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.